Ranking Alexa Global: # 4,203,358
Server:nginx...
The main IP address: 35.197.197.210,Your server United States,Ann Arbor ISP:Merit Network Inc. TLD:com CountryCode:US
The description :videos contact blog search lung cancer test early cdt-lung – test validation lung nodule – malignancy risk assessment lung nodule – test result interpretation lung cancer – early diagnosis lung cancer...
This report updates in 30-Jul-2018
Created Date: | 2003-01-31 |
Changed Date: | 2014-12-09 |
Expires Date: | 2020-01-31 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host oncimmune.com. Currently, hosted in United States and its service provider is Merit Network Inc. .
Latitude: | 42.259864807129 |
Longitude: | -83.71989440918 |
Country: | United States (US) |
City: | Ann Arbor |
Region: | Michigan |
ISP: | Merit Network Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.
X-Type: | default |
X-Cache: | MISS |
Content-Encoding: | gzip |
Transfer-Encoding: | chunked |
X-Cache-Group: | normal |
Vary: | Accept-Encoding,Cookie |
Keep-Alive: | timeout=20 |
X-Cacheable: | SHORT |
Server: | nginx |
X-Pass-Why: | |
Connection: | keep-alive |
Link: | |
Cache-Control: | max-age=600, must-revalidate |
Date: | Sun, 29 Jul 2018 20:33:21 GMT |
WPE-Backend: | apache |
X-WPE-Loopback-Upstream-Addr: | 127.0.0.1:6789 |
Content-Type: | text/html; charset=UTF-8 |
soa: | a.ns.joker.com. hostmaster.joker.com. 2017122064 10240 7200 1209600 3600 |
txt: | "v=spf1 include:spf.protection.outlook.com -all" |
ns: | a.ns.joker.com. b.ns.joker.com. c.ns.joker.com. |
ipv4: | IP:35.197.197.210 ASN:15169 OWNER:GOOGLE - Google LLC, US Country:US |
mx: | MX preference = 10, mail exchanger = oncimmune-com.mail.protection.outlook.com. |
videos contact blog search lung cancer test early cdt-lung – test validation lung nodule – malignancy risk assessment lung nodule – test result interpretation lung cancer – early diagnosis lung cancer – general risk assessment general risk assessment – test result interpretation how to get early cdt-lung early cdt-lung – insurance & billing early cdt-lung – papers & publications early cdt-lung kit liver cancer test how to get early cdt-liver early cdt-liver – further literature early cdt-liver – insurance & billing about oncimmune leadership board of directors scientific advisory board science committee lung clinical advisory group press releases regulation & quality order early cdt tests order early cdt-lung order early cdt-liver contact us investors corporate governance regulatory newsflow share price and tools shareholder analysis analyst coverage results, reports & presentations corporate documents investor & advisor contacts aim rule 26 lung cancer test early cdt-lung – test validation lung nodule – malignancy risk assessment lung nodule – test result interpretation lung cancer – early diagnosis lung cancer – general risk assessment general risk assessment – test result interpretation how to get early cdt-lung early cdt-lung – insurance & billing early cdt-lung – papers & publications early cdt-lung kit liver cancer test how to get early cdt-liver early cdt-liver – further literature early cdt-liver – insurance & billing about oncimmune leadership board of directors scientific advisory board science committee lung clinical advisory group press releases regulation & quality order early cdt tests order early cdt-lung order early cdt-liver contact us investors corporate governance regulatory newsflow share price and tools shareholder analysis analyst coverage results, reports & presentations corporate documents investor & advisor contacts aim rule 26 home oncimmune patient care program autoantibody technology privacy policy early cdt-lung order form for the us blog lung cancer test early cdt-lung – test validation lung nodule – malignancy risk assessment lung nodule – test result interpretation lung cancer – early diagnosis lung cancer – general risk assessment general risk assessment – test result interpretation how to get early cdt-lung early cdt-lung – insurance & billing early cdt-lung – papers & publications early cdt-lung kit liver cancer test how to get early cdt-liver early cdt-liver – further literature early cdt-liver – insurance & billing about oncimmune leadership board of directors scientific advisory board science committee lung clinical advisory group press releases regulation & quality order early cdt tests order early cdt-lung order early cdt-liver contact us investors corporate governance regulatory newsflow share price and tools shareholder analysis analyst coverage results, reports & presentations corporate documents investor & advisor contacts aim rule 26 oncimmune is a leading early cancer testing business. our proprietary technology can be used for most solid tumor types read more... our simple blood test for lung cancer can be used in conjunction with ct and other imaging to assess the risk of having lung cancer read more... early cdt®-lung significantly aids the malignancy risk assessment of lung nodules. our lung cancer test has high specificity and ppv and so can be used to rule-in for lung cancer. read more... early cdt®-lung test is available now in the us, europe, asia and the middle east order now... early cdt®-liver is a simple blood test to aid detection and confirmation of hcc in association with imaging, in high-risk patients with liver lesions of all sizes read more... read more about our lung cancer test using early cdt-lung for nodule risk assessment latest news oncimmune publishes study showing cost-effectiveness of early cdt-lung test in early detection of lung cancer in patients with indeterminate pulmonary nodules read more order early cdt tests read more about our liver cancer test early cdt-lung case study - dr. kucera please read the following statement carefully electronic versions of the materials you are seeking to access are being made available on this website by oncimmune holdings plc (the “company”). these materials are not directed to nor are they intended for access by persons located or resident in the united states, australia, canada, south africa, japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. none of the securities of company discussed or referred to in the materials you are seeking to access have been registered under the us securities act or 1933, as amended (the “securities act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of rule 903 or rule 904 of regulation s under the securities act, (2) pursuant to an effective registration statement under the securities act, or (3) pursuant to an available exemption from the registration requirements of the securities act, in each case in accordance with all applicable securities laws. by clicking the “submit” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the united states and do not have a registered address in, and are not resident or located in, australia, canada, south africa or japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website. please click on the button below to confirm that you have read, understood and agree with the disclaimer above. yes, i accept no, i don't accept we use cookies to improve your visit. by continuing to browse our site, you accept our cookie policy. our cookie policy cookie policy okay, thanks terms & conditions | cookies oncimmune limited clinical sciences building, nottingham city hospital hucknall road, nottingham, ng5 1pb, united kingdom +44 (0) 115 82 31869 oncimmune (usa) llc 8960 commerce drive, building #6, de soto, ks 66018, usa +1 913 583 9000
http://oncimmune.com/investors/corporate-documents/
http://oncimmune.com/home/blog/
http://oncimmune.com/about-oncimmune/leadership/
http://oncimmune.com/liver-cancer-test/earlycdt-liver-further-literature/
http://oncimmune.com/liver-cancer-test/
http://oncimmune.com/home/oncimmune-patient-care-program/
http://oncimmune.com/about-oncimmune/board-of-directors/
http://oncimmune.com/lung-cancer-test/earlycdt-lung-insurance-billing/
http://oncimmune.com/lung-cancer-test/earlycdt-lung-how-it-works/
http://oncimmune.com/terms-and-conditions/
http://oncimmune.com/home/privacy-policy/
http://oncimmune.com/lung-cancer-test/lung-nodule-malignancy-risk-assessment/
http://oncimmune.com/investors/
http://oncimmune.com/home/testimonial-videos/
http://oncimmune.com/liver-cancer-test/how-to-get-earlycdt-liver/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: oncimmune.com
Registry Domain ID: 94550437_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.joker.com
Registrar URL: http://joker.com/
Updated Date: 2014-12-09T14:15:42Z
Creation Date: 2003-01-31T13:03:12Z
Registrar Registration Expiration Date: 2020-01-31T12:02:55Z
Registrar: CSL Computer Service Langenbach GmbH d/b/a joker.com
Registrar IANA ID: 113
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +49.21186767447
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID:
Registrant Name: Angelina Birmpili
Registrant Organization: OncImmune Ltd
Registrant Street: Clinical Sciences Building
Registrant Street: City Hospital, Hucknall Road
Registrant City: Nottingham
Registrant Postal Code: NG5 1PB
Registrant Country: GB
Registrant Phone: +44.1158231825
Registrant Fax: +44.1158231958
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Domain Admin
Admin Organization: PIPEX Communications Hosting Ltd
Admin Street: Portland Street
Admin Street: Beesting
Admin City: Nottingham
Admin State/Province: Notts
Admin Postal Code: NG9 2LP
Admin Country: GB
Admin Phone: +44.09002211123
Admin Fax: +011.58770213
Admin Email: [email protected]
Registry Tech ID:
Tech Name: Domain Admin
Tech Organization: PIPEX Communications Hosting Ltd
Tech Street: Portland Street
Tech Street: Beesting
Tech City: Nottingham
Tech State/Province: Notts
Tech Postal Code: NG9 2LP
Tech Country: GB
Tech Phone: +44.09002211123
Tech Fax: +011.58770213
Tech Email: [email protected]
Name Server: a.ns.joker.com
Name Server: b.ns.joker.com
Name Server: c.ns.joker.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-06-19T16:23:44Z <<<
Query Time: 0.116606
Query Source: 45.33.85.57
WHOIS Source: joker.com live whois service
For more information on Whois status codes, please visit https://icann.org/epp
NOTE: By submitting a WHOIS query, you agree to abide by the following
NOTE: terms of use: You agree that you may use this data only for lawful
NOTE: purposes and that under no circumstances will you use this data to:
NOTE: (1) allow, enable, or otherwise support the transmission of mass
NOTE: unsolicited, commercial advertising or solicitations via direct mail,
NOTE: e-mail, telephone, or facsimile; or (2) enable high volume, automated,
NOTE: electronic processes that apply to Joker.com (or its computer systems).
NOTE: The compilation, repackaging, dissemination or other use of this data
NOTE: is expressly prohibited without the prior written consent of Joker.com.
REGISTRAR CSL COMPUTER SERVICE LANGENBACH GMBH D/B/A JOKER.COM
REFERRER http://www.joker.com
SERVERS
SERVER com.whois-servers.net
ARGS domain =oncimmune.com
PORT 43
SERVER whois.joker.com
ARGS oncimmune.com
PORT 43
TYPE domain
DOMAIN
NAME oncimmune.com
NSERVER
A.NS.JOKER.COM 184.172.157.218
B.NS.JOKER.COM 159.25.97.69
C.NS.JOKER.COM 159.25.49.66
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
CHANGED 2014-12-09
CREATED 2003-01-31
EXPIRES 2020-01-31
DOMAIN NAME oncimmune.com
REGISTRY DOMAIN ID 94550437_DOMAIN_COM-VRSN
REGISTRAR WHOIS SERVER whois.joker.com
REGISTRAR URL http://joker.com/
UPDATED DATE 2014-12-09T14:15:42Z
CREATION DATE 2003-01-31T13:03:12Z
REGISTRAR REGISTRATION EXPIRATION DATE 2020-01-31T12:02:55Z
REGISTRAR CSL Computer Service Langenbach GmbH d/b/a joker.com
REGISTRAR IANA ID 113
REGISTRAR ABUSE CONTACT EMAIL [email protected]
REGISTRAR ABUSE CONTACT PHONE +49.21186767447
DOMAIN STATUS clientTransferProhibited https://icann.org/epp#clientTransferProhibited
REGISTRANT NAME Angelina Birmpili
REGISTRANT ORGANIZATION OncImmune Ltd
REGISTRANT STREET
Clinical Sciences Building
City Hospital, Hucknall Road
REGISTRANT CITY Nottingham
REGISTRANT POSTAL CODE NG5 1PB
REGISTRANT COUNTRY GB
REGISTRANT PHONE +44.1158231825
REGISTRANT FAX +44.1158231958
REGISTRANT EMAIL [email protected]
ADMIN NAME Domain Admin
ADMIN ORGANIZATION PIPEX Communications Hosting Ltd
ADMIN STREET
Portland Street
Beesting
ADMIN CITY Nottingham
ADMIN STATE/PROVINCE Notts
ADMIN POSTAL CODE NG9 2LP
ADMIN COUNTRY GB
ADMIN PHONE +44.09002211123
ADMIN FAX +011.58770213
ADMIN EMAIL [email protected]
TECH NAME Domain Admin
TECH ORGANIZATION PIPEX Communications Hosting Ltd
TECH STREET
Portland Street
Beesting
TECH CITY Nottingham
TECH STATE/PROVINCE Notts
TECH POSTAL CODE NG9 2LP
TECH COUNTRY GB
TECH PHONE +44.09002211123
TECH FAX +011.58770213
TECH EMAIL [email protected]
NAME SERVER
a.ns.joker.com
b.ns.joker.com
c.ns.joker.com
DNSSEC unsigned
URL OF THE ICANN WHOIS DATA PROBLEM REPORTING SYSTEM http://wdprs.internic.net/
>>> LAST UPDATE OF WHOIS DATABASE 2017-06-19T16:23:44Z <<<
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .